| 2026-05-14 |
详情>>
内部人交易：
McPeek Jennifer J等共交易6笔
|
| 2026-05-07 |
详情>>
股本变动：
变动后总股本23430.05万股
|
| 2026-05-07 |
详情>>
业绩披露：
2026年一季报每股收益-0.05美元,归母净利润-1260万美元,同比去年增长-763.16%
|
| 2026-05-07 |
财报披露：
美东时间 2026-05-07 盘前发布财报
|
| 2026-04-03 |
股东大会：
将于2026-05-14召开股东大会
会议内容 ▼▲
- 1.Election of the three nominees named in the Proxy Statement to the Board of Directors to a one-year term expiring at the 2027 annual general meeting: Jodie McLean, Timothy Wennes and Billie Williamson.
2.Appointment of KPMG LLP as independent auditor for the year ending December 31, 2026 and authorization of the Audit Committee to set the independent auditor’s remuneration.
3.Non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed in the Proxy Statement ("Say on Pay").
4.Approval of our 2026 Omnibus Share and Cash Incentive Plan.
|
| 2026-02-19 |
详情>>
业绩披露：
2023年年报每股收益-0.16美元,归母净利润-3540万美元,同比去年增长-118.02%
|
| 2026-02-19 |
详情>>
业绩披露：
2025年年报每股收益0.38美元,归母净利润8820.00万美元,同比去年增长-32.83%
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.48美元,归母净利润1.11亿美元,同比去年增长501.09%
|
| 2025-09-04 |
股东大会：
将于2025-10-16召开股东大会
会议内容 ▼▲
- 1.Scheme: Redomiciliation.
2.Approval of the Scheme.
3.Cushman & Wakefield Reduction of Capital.
4.Articles Amendments.
5.Issue of New Shares to New Cushman & Wakefield.
6.Adjournment (in case of insufficient votes).
7.Bye-law Provision: Board Declassification.
8.Bye-law Provision: Business Combinations.
9.Bye-law Provision: Authorization of Preference Shares.
10.Adjournment (in case of insufficient votes).
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益0.26美元,归母净利润5920.00万美元,同比去年增长486.93%
|
| 2025-05-30 |
股东大会：
将于2025-07-15召开股东大会
会议内容 ▼▲
- 1.Scheme: Redomiciliation.
2.Approval of the Scheme.
3.Cushman & Wakefield Reduction of Capital.
4.Issuance of New Shares to New Cushman & Wakefield.
5.Articles Amendment to Subject all Cushman & Wakefield Shares to the Scheme.
6.Adjournment (in case of insufficient votes).
7.Bye-law Provision: Board Declassification.
8.Bye-law Provision: Removal of Directors Only for Cause.
9.Bye-law Provision: Business Combinations.
10.Bye-law Provision: Authorization of Preference Shares.
|
| 2025-04-29 |
详情>>
业绩披露：
2025年一季报每股收益0.01美元,归母净利润190.00万美元,同比去年增长106.60%
|
| 2025-04-04 |
股东大会：
将于2025-05-15召开股东大会
会议内容 ▼▲
- 1.Election of directors
2.Ratification of KPMG LLP as independent registered public accounting firm
3.Appointment of KPMG LLP as U.K. Statutory Auditor
4.Authorization of the Audit Committee to determine the compensation of our U.K. Statutory Auditor
5.Non-binding, advisory vote on the compensation of Named Executive Officers as disclosed in this Proxy Statement (“Say-on-Pay”)
6.Non-binding, advisory vote on the frequency of future Say-on-Pay votes
7.Non-binding, advisory vote on the Directors’ Remuneration Report
8.Approval of an amendment to our Omnibus Management Share and Cash Incentive Plan
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益0.57美元,归母净利润1.31亿美元,同比去年增长470.90%
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益0.87美元,归母净利润1.96亿美元,同比去年增长-21.44%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.08美元,归母净利润1840.00万美元,同比去年增长117.49%
|
| 2024-07-30 |
详情>>
业绩披露：
2024年中报每股收益-0.07美元,归母净利润-1530万美元,同比去年增长78.54%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年一季报每股收益-0.13美元,归母净利润-2880万美元,同比去年增长62.30%
|
| 2024-04-05 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.Election of the three nominees named in the Proxy Statement to the Board of Directors: Michelle MacKay, Angela Sun and Rajesh Vennam.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our U.K. Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our U.K. Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed in the Proxy Statement (say-on-pay).
6.Non-binding, advisory vote on our Directors’ Remuneration Report.
7.Approval of our amended directors’ remuneration policy.
8.Approval of an amendment to our Omnibus Management Share and Cash Incentive Plan.
9.Approval of an amendment to our Omnibus Non-Employee Director Share and Cash Incentive Plan.
|
| 2023-04-06 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.Election of the three Class II Board nominated directors named in the Proxy Statement: Brett White, Jodie McLean and Billie Williamson.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our U.K. Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our U.K. Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed in the Proxy Statement (“Say-on-Pay”).
6.Non-binding, advisory vote on our director compensation report.
7.Approval of our amended director compensation policy.
8.Authorization of the Board to allot new shares in the Company and to grant rights to subscribe for, or to convert any security into, ordinary shares of the Company.
9.Authorization of the Board to disapply pre-emption rights when the Board allots ordinary shares of the Company for cash (special resolution).
|
| 2022-08-19 |
股东大会：
将于2022-09-21召开股东大会
会议内容 ▼▲
- 1.Vote to approve the repurchase authorization, form of share repurchase contracts and repurchase counterparties.
|
| 2022-04-07 |
股东大会：
将于2022-05-05召开股东大会
会议内容 ▼▲
- 1.Election of the three Class I Board nominated directors named in the Proxy Statement: Angelique Brunner, Jonathan Coslet and Anthony Miller.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our UK Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our UK Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our named executive officers (“Say-on-Pay”).
6.Non-binding, advisory vote on our director compensation report.
7.Vote to approve our amended director compensation policy.
8.Vote to approve an amendment and restatement of our 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-07 |
股东大会：
将于2021-05-06召开股东大会
会议内容 ▼▲
- 1.Election of the three Class III Board nominated directors named in the Proxy Statement: Timothy Dattels, Lincoln Pan and Rajeev Ruparelia.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our UK Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our UK Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our named executive officers (“Say-on-Pay”).
6.Non-binding, advisory vote on our director compensation report.
7.Vote to approve our revised director compensation policy.
8.Vote to approve an amendment and restatement of our 2018 Omnibus Management Share and Cash Incentive Plan.
9.Special resolution to adopt and approve Amended Articles of Association to permit us to hold virtual Annual General Meetings in the future.
|
| 2020-04-29 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.Election of the four Class II Board nominated directors named in the Proxy Statement: Brett White, Richard McGinn, Jodie McLean and Billie Williamson.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our UK Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our UK Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our named executive officers (“Say-on-Pay”).
6.Non-binding, advisory vote on our director compensation report.
|
| 2019-05-14 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.Election of the three Class I Board nominated directors named in the Proxy Statement: Jonathan Coslet, Qi Chen and Michelle MacKay.
2.Ratification of KPMG LLP as our independent registered public accounting firm.
3.Appointment of KPMG LLP as our UK Statutory Auditor.
4.Authorization of the Audit Committee to determine the compensation of our UK Statutory Auditor.
5.Non-binding, advisory vote on the compensation of our named executive officers (“Say-on-Pay”).
6.Non-binding, advisory vote on the frequency of future Say-on-Pay votes (“Say-on-Pay Frequency”).
7.Non-binding, advisory vote on our director compensation report.
8.Approval of our director compensation policy.
|